Antitrust partners in London, Düsseldorf and Brussels say 2025 could be strong for dealmaking despite tighter merger control ...

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

Pharmaceuticals announced positive top-line results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel ...

WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...

Big news out of Nashville, TN after a pharmaceutical company announced advance results from the Phase 2 Fight DMD trial in ...

Phase II will include adding a 6,575-square-foot addition and a 9,200-square-foot renovation to the Health Education Science ...

Marvel Phase 5 will be a distant memory soon. The Marvel Cinematic Universe's (MCU) current line-up of new movies and Disney Plus shows is set to end before July 1, so there aren't many projects ...

What is the moon phase today? Today, Feb. 3, 2025, the moon is 5 days old, in the waxing crescent phase of its lunar cycle. It is 32% illuminated. Moon phases reveal the passage of time in the ...

Attorney General Pam Bondi outlined a sea change in how her Justice Department plans to approach foreign influence campaigns ...

During a live event, Kathryn E. Beckermann, MD, PhD, discussed the treatment of RCC with insights from a recent trial on ...

The first successful phase II trial in Duchenne muscular dystrophy (DMD) heart disease rolled out from Cumberland Pharmaceuticals Inc., which said top-line findings from the experiment called Fight ...